The OmniAI BriefAI × pharma omnichannelSubscribe

For pharma omnichannel teams

AI moves fast.We show when it mattersfor omnichannel.

Daily signals and weekly perspective on what AI can change in pharma omnichannel now, what to prepare for over the next six months, and what can wait.

One free subscription includes both editions. The Daily only sends when a signal clears the editorial bar.

One subscription. Two cadences.

Two editions. Two different jobs.

The Daily reports movement. The Weekly tells you direction. Both arrive with one free subscription.

Daily EditionMon–Sat · Noon ET

What changed—and whether to care today.

One development, the exact pharma-commercial handoff, and a clear call: Act, Ask, Watch, or Ignore. Quiet days stay quiet.

90 sec–2 minSubscribe free
Weekly EditionMonday · 7:00 a.m. ET

What mattered—and what changes next.

One or two connected stories, a realistic 3- and 6-month horizon, accountable forecasts, and a meeting-ready decision tool.

5 min readSubscribe free

Prefer the complete rhythm? The Daily builds the signal ledger. The Weekly turns those signals into direction.

Get both editions

Editorial standards over content volume

Every issue has to earn its place.

We track major AI announcements and the platform documentation others skip, then test whether a real pharma-commercial decision changes.

01

The signal has to qualify

A major AI move or a decision-relevant platform change. If nothing clears the bar, we do not manufacture an edition.

02

The pharma connection has to be real

An exact owner, workflow, before-and-after path, and measure—not a pharma angle pasted onto general AI news.

03

The judgment has to help

A clear call today, plus a realistic view of what could change next across internal teams and external partners.

AI + Human collaboration

Pharma experience sets the judgment. Agent Jimmy widens the search.

AI news is abundant. The scarce part is knowing where it collides with operating reality. Jorge supplies the context and final call. Agent Jimmy searches wider, compares faster, and challenges the first answer.

Human editorOperating judgment

Jorge Herrera

Jorge has spent his career helping pharma teams turn customer strategy into engagement that works in the real world. Across Pfizer and now CSL, where he leads Omnichannel Customer Engagement for the US, he has worked at the intersection of brands, field teams, content, technology, data, and partners. That experience keeps The OmniAI Brief grounded in the decisions, handoffs, and constraints that determine whether a good idea actually reaches an HCP or patient well.

Connect with Jorge on LinkedIn
AI editorial agentResearch + challenge

Agent Jimmy

Agent Jimmy is Jorge’s AI editorial partner, built with ChatGPT and Codex. It searches broadly, compares sources, challenges easy conclusions, and helps follow an AI development through the real work of pharma commercial teams. It does not replace Jorge’s judgment; it gives that judgment more evidence, more questions, and a wider field of view. Jorge remains responsible for every story, every interpretation, and every published call.

The four-gate editorial system

Less news. More judgment. Visible reasons to act—or wait.

  1. 01Scan

    Find the major move and the implementation detail others skip.

  2. 02Score

    Test significance, pharma decision relevance, freshness, and evidence.

  3. 03Translate

    Name the owner, workflow, 30/90/180-day horizon, and measure.

  4. 04Red-team

    Challenge the evidence, originality, usefulness, and human voice.

What the reader gets

A Daily that is allowed to stay silent. A Weekly that connects the signal to internal teams, vendors, agencies, and the operating decisions likely to change next.

The OmniAI Brief is an independent publication. Views are personal and do not represent or imply endorsement by current or former employers.

Both editions. One subscription.

Know what moved. Decide what changes.